XML 18 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Series B Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total Neonode Inc. Stockholders' Equity
Noncontrolling Interests
Balances at Dec. 31, 2014 $ 3,270 $ 40 $ 169,010 $ 149 $ (165,929) $ 3,270
Balances, shares at Dec. 31, 2014   83 40,455          
Stock option compensation expense to employees, directors and vendors 1,075 1,075 1,075
Proceeds from sale of common stock and pre-funded warrants, net of offering costs 5,422 $ 3 5,419 5,422
Proceeds from sale of common stock and pre-funded warrants, net of offering costs, shares   3,200          
Common stock issued upon exercise of common stock warrants 1 $ 1 1
Common stock issued upon exercise of common stock warrants, shares   151          
Foreign currency translation adjustment (103) (103) (103)
Noncontrolling interests Pronode initial contribution 3 3
Net loss (7,835) (7,820) (7,820) (15)
Balances at Dec. 31, 2015 1,833 $ 44 175,504 46 (173,749) 1,845 (12)
Balances, shares at Dec. 31, 2015   83 43,806          
Stock option compensation expense to employees, directors and vendors 255 255 255
Proceeds from sale of common stock and pre-funded warrants, net of offering costs 7,913 $ 5 7,908 7,913
Proceeds from sale of common stock and pre-funded warrants, net of offering costs, shares   5,027          
Common stock issued upon exercise of common stock warrants
Common stock issued upon exercise of common stock warrants, shares   12          
Foreign currency translation adjustment (217) (217) (217)
Net loss (5,649) (5,291) (5,291) (358)
Balances at Dec. 31, 2016 4,135 $ 49 183,667 (171) (179,040) 4,505 (370)
Balances, shares at Dec. 31, 2016   83 48,845          
Stock option compensation expense to employees, directors and vendors 72 72 72
Proceeds from sale of common stock and pre-funded warrants, net of offering costs 9,079 $ 10 9,069     9,079  
Proceeds from sale of common stock and pre-funded warrants, net of offering costs, shares   9,750    
Foreign currency translation adjustment 72 $ 72 72
Net loss (5,495) (4,705) (4,705) (790)
Balances at Dec. 31, 2017 $ 7,863 $ 59 $ 192,808 $ (99) $ (183,745) $ 9,023 $ (1,160)
Balances, shares at Dec. 31, 2017   83 58,595